Breaking News
Get 40% Off 0
🚀 AI-picked stocks soar in May. PRFT is +55%—in just 16 days! Don’t miss June’s top picks. Unlock full list
Close

Bristol-Myers Squibb Company (BMY)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
39.13 +0.81    +2.11%
22:08:45 - Delayed Data. Currency in EUR ( Disclaimer )
  • Volume: 3,692
  • Bid/Ask: 38.37 / 39.15
  • Day's Range: 38.40 - 39.20
Type:  Equity
Market:  Germany
ISIN:  US1101221083 
S/N:  850501
Bristol-Myers Squibb 39.13 +0.81 +2.11%

BMY Cash Flow Statement

 
Featured here, the Cash Flow Statement for Bristol-Myers Squibb Company, showing the changes in the company's cash and cash equivalents, broken down to operating, investing and financing activities over each of the last 4 periods (either quarterly or annually).
AnnualQuarterly
Advanced Cash Flow Statement
Period Ending: 2024
31/03
2023
31/12
2023
30/09
2023
30/06
Period Length: 0 Months 0 Months 0 Months 0 Months
Net Income/Starting Line -11911 1762 1928 2073
Cash From Operating Activities 2834 4252 4751 1887
Depreciation/Depletion 141 121 151 151
Amortization 2329 2300 2300 2300
Deferred Taxes -711 -1327 -327 -1086
Non-Cash Items 12049 -786 81 -937
Cash Receipts - - - -
Cash Payments - - - -
Cash Taxes Paid 187 4300 - -
Cash Interest Paid 308 268 293 315
Changes in Working Capital 198 855 291 -1700
Cash From Investing Activities -19618 -1346 -410 -329
Capital Expenditures -284 -330 -342 -259
Other Investing Cash Flow Items, Total -19334 -1016 -68 -70
Cash From Financing Activities 14644 967 -5160 -2173
Financing Cash Flow Items -97 25 41 53
Total Cash Dividends Paid -1212 -1160 -1191 -1197
Issuance (Retirement) of Stock, Net - - -4000 -905
Issuance (Retirement) of Debt, Net 15953 2102 -10 -124
Foreign Exchange Effects -16 58 14 -44
Net Change in Cash -2185 3951 -857 -623
Beginning Cash Balance 11515 7513 8371 8995
Ending Cash Balance 9330 11464 7514 8372
Free Cash Flow 5157 4836.62 3661 2677.62
Free Cash Flow Growth 6.62 32.11 36.73 4.29
Free Cash Flow Yield 2.32 3.77 3.69 1.22
* In Millions of USD (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the cash flow statement, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

BMY Comments

Write your thoughts about Bristol-Myers Squibb Co
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email